Search Results - Kenji Furukawa

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    A phase I study of high dose camostat mesylate in healthy adults provides a rationale to repurpose the TMPRSS2 inhibitor for the treatment of COVID‐19 by Junsaku Kitagawa, Hayato Arai, Hiroyuki Iida, Jiro Mukai, Kenji Furukawa, Seitaro Ohtsu, Susumu Nakade, Tomohiro Hikima, Miwa Haranaka, Naoto Uemura

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: